
Is methicillin-resistant Staphylococcus aureus involved in community acquired skin and soft tissue infections?: Experience from a tertiary care centre in Mumbai
Author(s) -
RS Phakade,
Gita Nataraj,
Sunil Kuyare,
US Khopkar,
PR Mehta
Publication year - 2012
Publication title -
journal of postgraduate medicine/journal of postgraduate medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 52
eISSN - 0972-2823
pISSN - 0022-3859
DOI - 10.4103/0022-3859.93245
Subject(s) - clindamycin , medicine , staphylococcus aureus , microbiology and biotechnology , cefazolin , erythromycin , gentamicin , methicillin resistant staphylococcus aureus , penicillin , ciprofloxacin , antibiotic resistance , fusidic acid , antibiotics , bacteria , biology , genetics
To improve the empiric antimicrobial therapy of community-acquired (CA) skin and soft tissue infections (SSTIs), it is necessary to generate data on the current spectrum and susceptibility profile of associated bacteria. CA methicillin-resistant Staphylococcus aureus (CA MRSA) is increasingly being reported in SSTIs in India and globally.